FDA Drug Application (206829) for ZERBAXA by CUBIST PHARMS LLC

Back to FDA Applications sponsored by CUBIST PHARMS LLC

Application Number206829
Product Number001
FormPOWDER;IV (INFUSION)
DosageEQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZERBAXA
Active IngredientCEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

Active IngredientCount
List of drugs with Active Ingredient TAZOBACTAM SODIUM4


Back to FDA Applications sponsored by CUBIST PHARMS LLC